Hear perspectives from industry, policy and academia on attracting and retaining talent, the role of economic incentives, and how global funding and policy can help build a sustainable, diverse antimicrobial research community.
Speakers:
- Heike Brötz-Oesterhelt, Professor of Microbiology, Dept. of Microbial Bioactive Compounds, University of Tübingen (Germany)
- Marc Lemonnier, CEO of Antabio SAS (France)
- Alexandra Cameron, Senior Technical Officer at WHO (Switzerland)
- Jonathan Stokes, Assistant Professor at the Department of Biochemistry and Biomedical Sciences at McMaster University (Canada)
Moderator:
- Lesley Ogilvie, Secretariat Director at the Global AMR R&D Hub (Germany)